Divis Laboratories Ltd.
- ECONOMY
Cherry-Picking The Nifty-50 ‘Chartbusters’: Motilal Oswal
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Preview – Price Erosions In The U.S., Other Markets To Drive Muted Growth In Sales: KRChoksey
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma, Healthcare Q1 Preview – Expect Tepid Performance With High Base, Elevated Costs: ICICI Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Recovery In U.S. But High Domestic Base To Weigh: ICICI Direct
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q1 FY23 Earnings Preview – A Glass Half-Full: Motilal Oswal
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Q3 Earnings Review – Festive Season Brings Limited Cheer; Cost Inflation Impairs Gross Margins: Motilal Oswal
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More »
